Prepared for Mark | Delivered August 2, 2020
Review your project details
To provide an overview of Pall Corporation, covering its background, markets it participated in, M&A, main product segments, revenues by segment, competitors by market, as well as potential segments to enter and operate.
Pall Corporation is a
in high-tech filtration and separation. The firm was
by Danaher Corporation in 2015.
Prior to its acquisition by Danaher Corporation, Pall was a public company and was
on the New York Stock Exchange. Danaher acquired Pall at
per share or
. The transaction represents a
premium for Pall's shareholders.
Although Pall Corporation was fully absorbed in the transaction, it currently acts as an indirect wholly-owned
of Danaher and maintains its identity. The company consists of two major divisions: The Paul
division, which is focused on filtration, vaccine development, and advanced medical technologies, and the
division, which focuses more on semiconductors, aerospace vehicles, and energy solutions.
Prior to the acquisition, Pall Corporation generated the
of its revenue from its Life Science division. According to its last 10K filing, the Life Science division represented
of its total sales, while the Industrial division accounted for the rest
Its last reported annual revenue (for FY 2014) was
Danaher Corporation does not highlight the performance of Pall's operations in its annual report. Rather, the firm only reports its sales by segment and not by subsidiaries. According to Danaher's last annual report, its Life Science division generated a total of
, and the company generated a total of